Sym001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sym001, covering 2019-01-30 to 2019-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) [Phase 2]